Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $184.1500 (-1.06%) ($183.8150 - $184.1500) on Thu. Jul. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.78% (three month average) | RSI | 39 | Latest Price | $184.1500(-1.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -0.2% a day on average for past five trading days. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) VYM(30%) VFMO(28%) XLP(27%) XLF(26%) | Factors Impacting UTHR price | UTHR will decline at least -0.89% in a week (0% probabilities). VIXM(-22%) VXX(-16%) UUP(-12%) BND(-4%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.89% (StdDev 1.78%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $184.73 | 5 Day Moving Average | $184.82(-0.36%) | 10 Day Moving Average | $184.56(-0.22%) | 20 Day Moving Average | $184.73(-0.31%) | To recent high | -9.7% | To recent low | 8% | Market Cap | $8.168b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |